UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Autoantibodies against complement component C1q in systemic lupus erythematosus

Clinical & translational immunology, 2021, Vol.10 (4), p.e1279-n/a

Trendelenburg, Marten

2021

Link zum Volltext

Verfügbarkeit prüfen

C1q as a target molecule to treat human disease: What do mouse studies teach us?

Frontiers in immunology, 2022-08, Vol.13, p.958273-958273

2022

Link zum Volltext

Verfügbarkeit prüfen

Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in Macrophages

The Journal of immunology (1950), 2016-03, Vol.196 (5), p.2063-2074

2016

Link zum Volltext

Verfügbarkeit prüfen

Clinical presentation of human C1q deficiency: How much of a lupus?

Molecular immunology, 2015-09, Vol.67 (1), p.3-11

2015

Link zum Volltext

Verfügbarkeit prüfen

The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury-Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor

Frontiers in immunology, 2018-05, Vol.9, p.1151-1151

2018

Link zum Volltext

Verfügbarkeit prüfen

Anti-C1q antibodies as a follow-up marker in SLE patients

PloS one, 2015-04, Vol.10 (4), p.e0123572-e0123572

2015

Link zum Volltext

Verfügbarkeit prüfen

Anti‐C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages

Journal of leukocyte biology, 2017-02, Vol.101 (2), p.481-491

2017

Link zum Volltext

Verfügbarkeit prüfen

The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography

PloS one, 2018-10, Vol.13 (10), p.e0202105-e0202105

2018

Link zum Volltext

Verfügbarkeit prüfen

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System

Frontiers in immunology, 2020-08, Vol.11, p.2072-2072

2020

Link zum Volltext

Verfügbarkeit prüfen

Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages

Frontiers in immunology, 2019-11, Vol.10, p.2712-2712

2019

Link zum Volltext

Verfügbarkeit prüfen

Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways

Clinical immunology (Orlando, Fla.), 2015-10, Vol.160 (2), p.180-187

2015

Link zum Volltext

Verfügbarkeit prüfen

Complement C1q and von Willebrand factor interaction in atherosclerosis of human carotid artery

Frontiers in immunology, 2023-12, Vol.14, p.1265387-1265387

2023

Link zum Volltext

Verfügbarkeit prüfen

Anti‐C1q autoantibodies from systemic lupus erythematosus patients enhance CD40–CD154‐mediated inflammation in peripheral blood mononuclear cells in vitro

Clinical & translational immunology, 2022, Vol.11 (8), p.e1408-n/a

2022

Link zum Volltext

Verfügbarkeit prüfen

Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study

Frontiers in immunology, 2021-10, Vol.12, p.765330-765330

2021

Link zum Volltext

Verfügbarkeit prüfen

Worse cardiovascular and renal outcome in male SLE patients

Scientific reports, 2023-10, Vol.13 (1), p.18628-18628, Article 18628

2023

Link zum Volltext

Verfügbarkeit prüfen

Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases

Frontiers in immunology, 2020-09, Vol.11, p.562564-562564

2020

Link zum Volltext

Verfügbarkeit prüfen

Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study

Frontiers in immunology, 2022-09, Vol.13, p.941742-941742

2022

Link zum Volltext

Verfügbarkeit prüfen

Complement C1s deficiency in a male Caucasian patient with systemic lupus erythematosus: a case report

Frontiers in immunology, 2023, Vol.14, p.1257525-1257525

2023

Link zum Volltext

Verfügbarkeit prüfen

Complement C1q Enhances Primary Hemostasis

Frontiers in immunology, 2020-07, Vol.11, p.1522-1522

2020

Link zum Volltext

Verfügbarkeit prüfen

Autoantibodies against Complement C1q Specifically Target C1q Bound on Early Apoptotic Cells

The Journal of immunology (1950), 2009-09, Vol.183 (5), p.3512-3521

2009

Link zum Volltext

Verfügbarkeit prüfen

Case Report-Secondary Antibody Deficiency Due to Endogenous Hypercortisolism

Frontiers in immunology, 2020-07, Vol.11, p.1435

2020

Link zum Volltext

Verfügbarkeit prüfen

Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site

Frontiers in immunology, 2019-11, Vol.10, p.2619-2619

2019

Link zum Volltext

Verfügbarkeit prüfen

Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial

Respiratory research, 2021-08, Vol.22 (1), p.227-227, Article 227

2021

Link zum Volltext

Verfügbarkeit prüfen

Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus

Frontiers in immunology, 2022-01, Vol.12, p.761395-761395

2022

Link zum Volltext

Verfügbarkeit prüfen

Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients

PloS one, 2011-06, Vol.6 (6), p.e21338-e21338

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 136

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(128)
Mit Volltextzugriff
(119)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(83)
Humans
(78)
Female
(55)
Male
(53)
Immunology
(46)
Adult
(37)
Middle Aged
(34)
Aged
(29)
Systemic Lupus Erythematosus
(28)
Lupus Erythematosus, Systemic - Immunology
(21)
Complement C1q - Immunology
(18)
Lupus
(18)
Complement
(17)
Autoimmune Diseases
(16)
Biological And Medical Sciences
(16)
Medical Sciences
(16)
Patients
(16)
Rheumatology
(16)
Aged, 80 And Over
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Autoantibodies against complement component C1q in systemic lupus erythematosus

C1q as a target molecule to treat human disease: What do mouse studies teach us?

Anti-C1q Autoantibodies from Systemic Lupus Erythematosus Patients Induce a Proinflammatory Phenotype in Macrophages

Clinical presentation of human C1q deficiency: How much of a lupus?

The Lectin Pathway of Complement in Myocardial Ischemia/Reperfusion Injury-Review of Its Significance and the Potential Impact of Therapeutic Interference by C1 Esterase Inhibitor

Anti-C1q antibodies as a follow-up marker in SLE patients

Anti‐C1q autoantibodies from patients with systemic lupus erythematosus induce C1q production by macrophages

The heart in systemic lupus erythematosus - A comprehensive approach by cardiovascular magnetic resonance tomography

Treatment of COVID-19 With Conestat Alfa, a Regulator of the Complement, Contact Activation and Kallikrein-Kinin System

Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages

Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways

Complement C1q and von Willebrand factor interaction in atherosclerosis of human carotid artery

Anti‐C1q autoantibodies from systemic lupus erythematosus patients enhance CD40–CD154‐mediated inflammation in peripheral blood mononuclear cells in vitro

Functional Activity of the Complement System in Hospitalized COVID-19 Patients: A Prospective Cohort Study

Worse cardiovascular and renal outcome in male SLE patients

Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases

Complement and endothelial cell activation in COVID-19 patients compared to controls with suspected SARS-CoV-2 infection: A prospective cohort study

Complement C1s deficiency in a male Caucasian patient with systemic lupus erythematosus: a case report

Complement C1q Enhances Primary Hemostasis

Autoantibodies against Complement C1q Specifically Target C1q Bound on Early Apoptotic Cells

Case Report-Secondary Antibody Deficiency Due to Endogenous Hypercortisolism

Anti-C1q Antibodies as Occurring in Systemic Lupus Erythematosus Could Be Induced by an Epstein-Barr Virus-Derived Antigenic Site

Association of mannose-binding lectin, ficolin-2 and immunoglobulin concentrations with future exacerbations in patients with chronic obstructive pulmonary disease: secondary analysis of the randomized controlled REDUCE trial

Epitope-Specific Anti-C1q Autoantibodies in Systemic Lupus Erythematosus

Mannose-binding lectin deficiency is associated with smaller infarction size and favorable outcome in ischemic stroke patients

Suchergebnisse filtern